Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick P J Phillips

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
Breathe (Sheffield, England)|October 13, 2023
Treatment-shortening regimens for tuberculosis: updates and future prioritiesFrancesca Saluzzo, Victor Abiola Adepoju, Raquel Duarte, et al.
The Lancet. Infectious Diseases|November 29, 2024
Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic reviewWilliam Burman, Pauline Luczynski, C Robert Horsburgh, et al.
Trials|July 3, 2016
Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomesDaniel J Bratton, Mahesh K B Parmar, Patrick P J Phillips, et al.
The Lancet. Infectious Diseases|May 25, 2019
STREAM: a pragmatic and explanatory trial for MDR-TB treatmentIbrahim Abubakar, Sarah Meredith, Andrew J Nunn, et al.
BMJ Open|November 18, 2016
Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journalsSunita Rehal, Tim P Morris, Katherine Fielding, et al.
The Lancet. Infectious Diseases|March 10, 2015
Shortening treatment of tuberculosis: lessons from fluoroquinolone trialsCamus Nimmo, Marc Lipman, Patrick P J Phillips, et al.
The Pediatric Infectious Disease Journal|November 1, 2014
Short intensified treatment in children with drug-susceptible tuberculous meningitisAnna Turkova, James A Seddon, Andrew J Nunn, et al.
The European Respiratory Journal|May 2, 2016
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in ChinaCatherine Berry, Tom A Yates, James A Seddon, et al.
BMC Medicine|March 24, 2016
World TB Day 2016: an interview with leading experts in tuberculosis researchPatrick P J Phillips, Helen A Fletcher, Ibrahim Abubakar, et al.
Clinical Trials (London, England)|July 17, 2012
When inferiority meets non-inferiority: implications for interim analysesDaniel J Bratton, Hywel C Williams, Brennan C Kahan, et al.
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
Breathe (Sheffield, England)|October 13, 2023
Treatment-shortening regimens for tuberculosis: updates and future prioritiesFrancesca Saluzzo, Victor Abiola Adepoju, Raquel Duarte, et al.
The Lancet. Infectious Diseases|November 29, 2024
Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic reviewWilliam Burman, Pauline Luczynski, C Robert Horsburgh, et al.
Trials|July 3, 2016
Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomesDaniel J Bratton, Mahesh K B Parmar, Patrick P J Phillips, et al.
The Lancet. Infectious Diseases|May 25, 2019
STREAM: a pragmatic and explanatory trial for MDR-TB treatmentIbrahim Abubakar, Sarah Meredith, Andrew J Nunn, et al.
BMJ Open|November 18, 2016
Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journalsSunita Rehal, Tim P Morris, Katherine Fielding, et al.
The Lancet. Infectious Diseases|March 10, 2015
Shortening treatment of tuberculosis: lessons from fluoroquinolone trialsCamus Nimmo, Marc Lipman, Patrick P J Phillips, et al.
The Pediatric Infectious Disease Journal|November 1, 2014
Short intensified treatment in children with drug-susceptible tuberculous meningitisAnna Turkova, James A Seddon, Andrew J Nunn, et al.
The European Respiratory Journal|May 2, 2016
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in ChinaCatherine Berry, Tom A Yates, James A Seddon, et al.
BMC Medicine|March 24, 2016
World TB Day 2016: an interview with leading experts in tuberculosis researchPatrick P J Phillips, Helen A Fletcher, Ibrahim Abubakar, et al.
Clinical Trials (London, England)|July 17, 2012
When inferiority meets non-inferiority: implications for interim analysesDaniel J Bratton, Hywel C Williams, Brennan C Kahan, et al.
Pageof 12